Advertisement

Topics

NuvOx Pharma and the University of Arkansas Initiate Phase Ib/II Clinical Trial in Stroke

06:00 EST 6 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
NuvOx Pharma announces that the first patients have been dosed in a Phase Ib/II clinical trial for NVX-208, an oxygen therapeutic being developed for acute ischemic stroke. The trial is being performed at the University of Arkan...

Other Sources for this Article

NuvOx Pharma
John McGonigle
jmcgonigle@nuvoxpharma.com

NEXT ARTICLE

More From BioPortfolio on "NuvOx Pharma and the University of Arkansas Initiate Phase Ib/II Clinical Trial in Stroke"

Advertisement
Quick Search
Advertisement
Advertisement